Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023

View ORCID ProfileMatthew J. Knight, View ORCID ProfileYuan Yu, View ORCID ProfileJiacheng Chen, View ORCID ProfileSheila F. O’Brien, View ORCID ProfileDavid L. Buckeridge, View ORCID ProfileCarmen Charlton, View ORCID ProfileW. Alton Russell
doi: https://doi.org/10.1101/2024.12.30.24319767
Matthew J. Knight
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew J. Knight
  • For correspondence: matthew.knight{at}mail.mcgill.ca
Yuan Yu
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuan Yu
Jiacheng Chen
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jiacheng Chen
Sheila F. O’Brien
2Canadian Blood Services, Ottawa, Canada
3School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sheila F. O’Brien
David L. Buckeridge
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada
4COVID-19 Immunity Task Force, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David L. Buckeridge
Carmen Charlton
5Canadian Blood Services, Edmonton, Canada
6Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carmen Charlton
W. Alton Russell
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada
4COVID-19 Immunity Task Force, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for W. Alton Russell
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Serological testing was a key component of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) surveillance. Social distancing interventions, resource limitations, and the need for timely data led to serosurveillance studies using a range of recruitment strategies, which likely influenced study representativeness. Characterizing representativeness in surveillance is crucial to identify gaps in sampling coverage and to assess health inequities.

Methods We retrospectively analyzed three pre-existing longitudinal cohorts, two convenience samples using residual blood, and one de novo probabilistic survey conducted in Canada between April 2020 – November 2023. We calculated study specimen counts by age, sex, urbanicity, race/ethnicity, and neighborhood deprivation quintiles. We derived a ‘representation ratio’ as a simple metric to assess generalizability to a target population and various sociodemographic strata.

Results The six studies included 1,321,675 specimens. When stratifying by age group and sex, 65% of racialized minority subgroups were moderately underrepresented (representation ratio < 0.75). Representation was generally higher for older Canadians, urban neighborhoods, and neighborhoods with low material deprivation. Rural representation was highest in a study that used outpatient laboratory blood specimens. Racialized minority representation was highest in a de novo probabilistic survey cohort.

Conclusion While no study had adequate representation of all subgroups, less traditional recruitment strategies were more representative of some population dimensions. Understanding demographic representativeness and barriers to recruitment are important considerations when designing population health surveillance studies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

WAR was supported by funding from Canadian Blood Services and the COVID-19 Immunity Task Force.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Faculty of Medicine and Health Sciences Research Ethics Board of McGill University gave ethical approval for this work (study number 22-03-077)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • This version of the manuscript contains a revised supplemental data file (STROBE checklist)

Data Availability

The authors are not authorized to share individual-level data from any study. Processes are available for researchers to request access to datasets for studies that have undergone institutional ethical approval. Data from Canadian Blood Services and Alberta Precision Laboratories may be made available upon request, subject to internal review, privacy legislation, data sharing agreements, and research ethics approval. The CCAHS-1 study by Statistics Canada can be analyzed for approved projects at Research Data Centres located across Canada (https://www.statcan.gc.ca/en/microdata/data-centres/access). Data are available from the Canadian Longitudinal Study on Aging (www.clsa-elcv.ca) for researchers who meet the criteria for access to de-identified CLSA data. Access to the Ab-C study data can be requested through the COVID-19 Immunity Task Force Databank (https://portal.citf.mcgill.ca/). Access to the CanPath data can be requested through the CanPath data portal (https://portal.canpath.ca/). Analytical code will be available in a public repository upon publication.

  • ABBREVIATIONS

    Ab-C
    Action to Beat Coronavirus
    APL
    Alberta Precision Laboratories
    CanPath
    Canadian Partnership for Tomorrow’s Health
    CBS
    Canadian Blood Services
    CCAHS-1
    Canadian COVID-19 Antibody and Health Survey 1
    CLSA
    Canadian Longitudinal Study on Aging
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus-2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted January 05, 2025.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023
    Matthew J. Knight, Yuan Yu, Jiacheng Chen, Sheila F. O’Brien, David L. Buckeridge, Carmen Charlton, W. Alton Russell
    medRxiv 2024.12.30.24319767; doi: https://doi.org/10.1101/2024.12.30.24319767
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023
    Matthew J. Knight, Yuan Yu, Jiacheng Chen, Sheila F. O’Brien, David L. Buckeridge, Carmen Charlton, W. Alton Russell
    medRxiv 2024.12.30.24319767; doi: https://doi.org/10.1101/2024.12.30.24319767

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (431)
    • Allergy and Immunology (757)
    • Anesthesia (221)
    • Cardiovascular Medicine (3298)
    • Dentistry and Oral Medicine (365)
    • Dermatology (280)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
    • Epidemiology (13385)
    • Forensic Medicine (19)
    • Gastroenterology (899)
    • Genetic and Genomic Medicine (5158)
    • Geriatric Medicine (482)
    • Health Economics (783)
    • Health Informatics (3276)
    • Health Policy (1143)
    • Health Systems and Quality Improvement (1193)
    • Hematology (432)
    • HIV/AIDS (1019)
    • Infectious Diseases (except HIV/AIDS) (14638)
    • Intensive Care and Critical Care Medicine (913)
    • Medical Education (478)
    • Medical Ethics (127)
    • Nephrology (525)
    • Neurology (4930)
    • Nursing (262)
    • Nutrition (730)
    • Obstetrics and Gynecology (886)
    • Occupational and Environmental Health (795)
    • Oncology (2524)
    • Ophthalmology (728)
    • Orthopedics (282)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (544)
    • Pediatrics (1302)
    • Pharmacology and Therapeutics (551)
    • Primary Care Research (557)
    • Psychiatry and Clinical Psychology (4218)
    • Public and Global Health (7512)
    • Radiology and Imaging (1708)
    • Rehabilitation Medicine and Physical Therapy (1016)
    • Respiratory Medicine (980)
    • Rheumatology (480)
    • Sexual and Reproductive Health (498)
    • Sports Medicine (424)
    • Surgery (549)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (205)